1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Ertugliflozin + metformin
Trade Name:
Segluromet
Manufacturer/Distributor:
Merck Canada
Classification:
Oral blood glucose lowering agents
ATC Class:
A10BD23 - metformin and ertugliflozin
Status:
active
Notice of Compliance (yyyy/mm/dd):
2018/05/30
Date Marketed in Canada (yyyy/mm/dd):
2018/05/30
Presentation:
Tablet: 2.5 mg ertugliflozin + 500 mg metformin. DIN: 0247615
Tablet: 2.5 mg ertugliflozin + 1000 mg metformin. DIN: 02476223
Tablet: 7.5 mg ertugliflozin + 500 mg metformin. DIN: 02476231
Tablet: 7.5 mg ertugliflozin + 1000 mg metformin. DIN: 02476258
Comments:
This combination product is used as an adjunct to diet and exercise in adult patients with type 2 diabetes who are inadequately controlled on metformin or already controlled with metformin and ertugliflozin as individual components. It is also indicated for use in combination with sitagliptin as an adjunct to diet and exercise in adult patients with type 2 diabetes mellitus who are inadequately controlled on metformin and sitagliptin, or already controlled with metformin, sitagliptin and ertugliflozin, as individual components components.
Back to:
Drug Product Listings 
